Daily Bulletin

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

Essential Steps to Take Immediately After a Traffic Violation Notice

Receiving a traffic violation notice can be quite unsettling, but responding promptly is crucial. Traffic violations, which may range from minor infractions to serious offences, can have significant...

Daily Bulletin - avatar Daily Bulletin

Promotional Products in Australia: A Cost-Effective Strategy for Brand Growth

In an era dominated by digital marketing, businesses are constantly exploring new ways to reach their audience and make a lasting impact. Amid the rapid evolution of online advertising, one tried-an...

Daily Bulletin - avatar Daily Bulletin

Moving? Your Move

Packing up and moving can be extremely time-consuming and stressful. Apparently, the stress caused can be the equivalent of losing a close family member, so yeah, that puts it into perspective. How ...

Daily Bulletin - avatar Daily Bulletin